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Autism spectrum disorder (ASD) comprises a range of neurological conditions that
affect individuals’ ability to communicate and interact with others. People with ASD
often exhibit marked qualitative difficulties in social interaction, communication, and
behavior. Alterations in neurite arborization and dendritic spine morphology, including
size, shape, and number, are hallmarks of almost all neurological conditions, including
ASD. As experimental evidence emerges in recent years, it becomes clear that
although there is broad heterogeneity of identified autism risk genes, many of them
converge into similar cellular pathways, including those regulating neurite outgrowth,
synapse formation and spine stability, and synaptic plasticity. These mechanisms
together regulate the structural stability of neurons and are vulnerable targets in ASD.
In this review, we discuss the current understanding of those autism risk genes
that affect the structural connectivity of neurons. We sub-categorize them into (1)
cytoskeletal regulators, e.g., motors and small RhoGTPase regulators; (2) adhesion
molecules, e.g., cadherins, NCAM, and neurexin superfamily; (3) cell surface receptors,
e.g., glutamatergic receptors and receptor tyrosine kinases; (4) signaling molecules,
e.g., protein kinases and phosphatases; and (5) synaptic proteins, e.g., vesicle and
scaffolding proteins. Although the roles of some of these genes in maintaining neuronal
structural stability are well studied, how mutations contribute to the autism phenotype is
still largely unknown. Investigating whether and how the neuronal structure and function
are affected when these genes are mutated will provide insights toward developing
effective interventions aimed at improving the lives of people with autism and their
families.
Keywords: autism-risk genes, neurite outgrowth, dendrite, dendritic spine, synapse formation, actin, adhesion
molecule
INTRODUCTION
Autism spectrum disorder (ASD) is a neurodevelopmental clinical condition currently diagnosed
based on the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-5) criteria reflecting symptoms, possibly of varying severity, in
social interaction, communication and behavior (American Psychiatric Association, 2013; Lord
and Jones, 2013). ASD occurs in 1:68 individuals in the United States (Baio, 2014) and complex
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genetic interactions appear responsible for a high degree of
heterogeneity of the clinical symptoms in ASD. Individuals
with ASD often co-express other comorbidities including
epilepsy which often complicates diagnosis and treatment.
Alterations in neuronal structures in different brain regions
have been reported in ASD individuals, including increased
dendritic spine density in cortical pyramidal neurons (Hutsler
and Zhang, 2010; Tang et al., 2014) as well as stunting
of dendritic branching in the hippocampus (Raymond
et al., 1996; Bauman and Kemper, 2005). In addition,
subcortical band heterotopia, representing alterations in
cell migration has also been found in a child with ASD
(Beaudoin et al., 2007). These brain regions are often
characterized with neuroanatomical irregularities in ASD
(Donovan and Basson, 2016). The defective regulation for
structural stability of neurons may be one of the underlying
mechanisms that contribute to the anatomical changes
in ASD.
Autism spectrum disorder is typically diagnosed during the
first 3 years of life, a period of extensive neurite formation,
synaptogenesis and refinement (Huttenlocher and Dabholkar,
1997; Zoghbi and Bear, 2012; Stamou et al., 2013; McGee et al.,
2014). Indeed, brain imaging studies from individuals with
ASD and anatomical measurements of neuronal structure in
post-mortem tissues exhibit differences in neuronal connectivity
derived from the disruption of neurite outgrowth, synapse
formation and stabilization (Raymond et al., 1996; Hutsler and
Zhang, 2010; Penzes et al., 2011). Studies of human induced
pluripotent stem cells (iPSCs) derived from people with ASD
also have identified defects of neuronal structure (Habela et al.,
2015; Nestor et al., 2015). Genome-wide association studies on
individuals with ASD and their families revealed several risk
genes that may be the common molecular targets in autism
(Bucan et al., 2009; Glessner et al., 2009; Hussman et al., 2011;
O’Roak et al., 2011, 2012a; Buxbaum et al., 2012, 2014; Sanders
et al., 2012; Shi et al., 2013; Stamou et al., 2013; Yu et al.,
2013; An et al., 2014; Brett et al., 2014; Cukier et al., 2014; De
Rubeis et al., 2014; Iossifov et al., 2014; McGee et al., 2014;
Pinto et al., 2014; Ronemus et al., 2014; Toma et al., 2014;
Yuen et al., 2015). Animal studies of these genes further identify
several specific cellular pathways during brain development
that are vulnerable in ASD, including the disruption of neurite
outgrowth, dendritic spine formation, and synaptic function
(Figure 1) (Walsh et al., 2008; Bourgeron, 2009; Hussman
et al., 2011; Penzes et al., 2011; Zoghbi and Bear, 2012; Ebert
and Greenberg, 2013; Stamou et al., 2013; Bernardinelli et al.,
2014; De Rubeis et al., 2014; Pinto et al., 2014; Phillips and
Pozzo-Miller, 2015). Differences in environment as well as the
presence of multiple gene mutations occurring in the same
individual with autism complicate studies of the relationship
between each gene and the phenotype observed. However,
because similar cellular pathways (e.g., neurite outgrowth) are
altered in different affected individuals, we can potentially
develop therapeutic interventions to help mitigate the autism
phenotypes.
During development, neurite outgrowth and synapse
formation are dynamic processes and their maturation is
FIGURE 1 | Diagram of autism-risk genes implicated in regulating the
structural stability of neurons. Each circle represents a cellular pathway to
regulate the structural stability of neurons, including neurite outgrowth (red),
dendritic spine or synapse formation (blue), and synaptic plasticity (gold).
Experimental evidence shows that many autism-risk genes regulate at least
one cellular pathway to maintain the integrity of neuronal structures. Genes
that regulate only one pathway are labeled in light gray. Genes that regulate
two pathways are labeled in dark gray. Genes that regulate three pathways
are labeled in black. The summaries of autism-risk genes that affect each
cellular pathway can be found in Tables 1–3.
mutually dependent on proper guidance. Neurites initially
exhibit frequent branch additions and retractions. Once dendrite
arbors are established, productive synapse formation later in
life and the accompanying activation of post-synaptic signaling
machinery promotes arbor stability (Dailey and Smith, 1996;
Wu and Cline, 1998; Rajan et al., 1999; Wong et al., 2000; Cline,
2001; Niell et al., 2004). Conversely, a loss of synaptic inputs
leads to dendritic loss (Jones and Thomas, 1962; Matthews
and Powell, 1962; Coleman and Riesen, 1968; Sfakianos et al.,
2007). This reciprocal regulation contributes to the refinement
of dendrites and synapses as the neurons mature (Wu et al.,
1999; Trachtenberg et al., 2002; Holtmaat et al., 2005; Koleske,
2013). Thus, maintaining the structural stability of neurons
and synapses is critical for proper brain function. Alterations
in these processes likely underlie the disruption of normal
dendrite and dendritic spine structure in neurological disorders,
including neurodevelopmental conditions, psychiatric disorders,
and neurodegenerative diseases (Fiala et al., 2002; Lin and
Koleske 2010; Penzes et al., 2011; Kulkarni and Firestein, 2012;
Zoghbi and Bear, 2012; Koleske, 2013; Bernardinelli et al.,
2014).
It is well-accepted that ASD is not a monogenetic disorder,
instead, it is often a neurological condition resulted from multiple
mutations of several different genes. Although knockout,
knockin, or transgenic approaches of autism-risk genes in
animal models have demonstrated some of the autistic-like
behaviors (Kazdoba et al., 2016), the limitation of the number
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 November 2016 | Volume 10 | Article 263
fncel-10-00263 November 15, 2016 Time: 15:51 # 3
Lin et al. Autism Genes Regulate Neuronal Structures
TABLE 1 | Summary of autism-associated genes that regulate neurite outgrowth.
Functional category Gene Representative references
Cytoskeletal regulator
MYO16 Patel et al., 2001; Yokoyama et al., 2011
CTTNBP2 Shih et al., 2014
ELMO1 Franke et al., 2012; Lanoue et al., 2013
Adhesion molecule
CDHs Esch et al., 2000; Bekirov et al., 2008; Tan et al., 2010; Friedman et al., 2015b
PCDH Uemura et al., 2007; Morrow et al., 2008; Keeler et al., 2015
NRXN Gjorlund et al., 2012
NLGN Gjorlund et al., 2012
CNTNAP2 Anderson et al., 2012
CNTN Ye et al., 2008
NCAM2 Sheng et al., 2015
Surface receptor
GRIN2B Ewald et al., 2008; Espinosa et al., 2009; Sepulveda et al., 2010; Bustos et al., 2014
NTRK Joo et al., 2014
Signaling molecule
DYRK1A Hammerle et al., 2003; Benavides-Piccione et al., 2005; Gockler et al., 2009; Lepagnol-Bestel et al.,
2009
CDKL5 Chen et al., 2010b; Amendola et al., 2014; Fuchs et al., 2014
PTEN Jaworski et al., 2005; Kwon et al., 2006; Zhou et al., 2009
Synaptic protein
STXBP5 Sakisaka et al., 2004
PRICKLE1 Liu et al., 2013a
Syndromic disorder related gene
FMR1 Galvez et al., 2003; Antar et al., 2006; Tucker et al., 2006; Berman et al., 2012; Amiri et al., 2014
MECP2 Fukuda et al., 2005; Jugloff et al., 2005; Zhou et al., 2006; Ballas et al., 2009; Belichenko et al., 2009;
Kishi and Macklis, 2010; Cohen et al., 2011; Marshak et al., 2012; Nguyen et al., 2012; Stuss et al.,
2012; Jiang et al., 2013a; Baj et al., 2014
UBE3A Dindot et al., 2008; Miao et al., 2013; Valluy et al., 2015
TSC1/2 Floricel et al., 2007; Choi et al., 2008
of genes being manipulated in animals makes it difficult to
recapitulate the human condition experimentally. Furthermore,
ASD is a common comorbid condition in individuals with other
neurodevelopmental disorders. The similar representation of
the symptoms but different contribution of genetic mutations
often complicates the diagnosis and the treatment. The complex
profile of gene mutations makes it difficult to call a gene
“the autism gene.” However, the list of autism-risk genes
provides us a direction to understand the potentially vulnerable
pathways in neurons that may be therapeutic targets to
develop more efficient interventions for ASD. Indeed, in
addition to the structural stability of neurons, several cellular
pathways including transcriptional regulation (De Rubeis et al.,
2014; Sanders, 2015), excitatory/inhibitory (E/I) balance (Blatt
et al., 2001; Hussman, 2001; Rubenstein and Merzenich, 2003;
Gao and Penzes, 2015; Nelson and Valakh, 2015), cerebellar
development (Wang et al., 2014; Hampson and Blatt, 2015),
and autoregulatory feedback loops (Mullins et al., 2016)
have been proposed to be vulnerable in autism. In this
review, we focus on recent identified autism-risk genes that
have been shown to regulate neuronal structures and circuit
formation, including aspects of neurite outgrowth (Table 1),
synapse formation and spine stability (Table 2), and synaptic
plasticity (Table 3). We will discuss the known biological
function of those individual autism-risk genes in neurons
and how they converge into common pathways. We have
categorized these genes into cytoskeletal regulators, adhesion
molecules, cell surface receptors, signaling molecules, as well
as synaptic proteins (Figure 2). In addition, we include genes
causing syndromic disorders in the discussion to highlight the
importance of maintaining the neuronal structures for proper
brain function.
CYTOSKELETAL REGULATION IS KEY
TO THE MAINTENANCE OF PROPER
STABILITY AND PLASTICITY OF
NEURONS
The actin and microtubule cytoskeletons are the major
components of dendritic spine and neurite structure,
respectively (Hoogenraad and Akhmanova, 2010; Hotulainen
and Hoogenraad, 2010; Dent et al., 2011; Shirao and Gonzalez-
Billault, 2013). Precise regulation of these actin and microtubule
networks is thus central to guide the proper development,
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ADNP Oz et al., 2014
CTTNBP2 Chen and Hsueh, 2012; Chen et al., 2012; Hsueh, 2012
SYNGAP1 Chen et al., 1998; Krapivinsky et al., 2004; Oh et al., 2004; Rumbaugh et al., 2006; Clement et al., 2012; Aceti
et al., 2015
ELMO1 Kim et al., 2011a
Adhesion molecule
CDHs Benson and Tanaka, 1998; Huntley and Benson, 1999; Bozdagi et al., 2000; Togashi et al., 2002; Paradis et al.,
2007; Suzuki et al., 2007; Bekirov et al., 2008; Williams et al., 2011; Friedman et al., 2015b
PCDH Tsai et al., 2012a
NRXN de Wit et al., 2009; Ko et al., 2009; Gokce and Sudhof, 2013
NLGN Scheiffele et al., 2000; Prange et al., 2004; Chih et al., 2005; Levinson et al., 2005; Varoqueaux et al., 2006;
Kwon et al., 2012;
CNTNAP2 Anderson et al., 2012; Gdalyahu et al., 2015; Varea et al., 2015
CNTN Li et al., 2003; Takeda et al., 2003; Sakurai et al., 2009, 2010; Toyoshima et al. 2009
Surface receptor
GRIN2B Akashi et al., 2009; Espinosa et al., 2009; Brigman et al., 2010; Ohno et al., 2010; Kelsch et al., 2012
GRIK2/4 Huettner, 2003; Lanore et al., 2012
NTRK Menn et al., 2000
Signaling molecule
DYRK1A Benavides-Piccione et al., 2005; Park et al., 2012; Thomazeau et al., 2014
CDKL5 Zhu et al., 2013; Della Sala et al., 2016
PTEN Kwon et al., 2006; Fraser et al., 2008; Luikart et al., 2011; Pun et al., 2012; Zhang et al., 2012; Haws et al.,
2014; Cupolillo et al., 2016
Synaptic protein
SHANK3 Sala et al., 2001; Roussignol et al., 2005; Hung et al., 2008; Peça et al., 2011; Verpelli et al., 2011; Wang et al.,
2011b; Peixoto et al., 2016
DLGAP2 Jiang-Xie et al., 2014
Syndromic disorder related gene
FMR1 Comery et al., 1997; Weiler and Greenough, 1999; Braun and Segal, 2000; Irwin et al., 2000; Nimchinsky et al.,
2001; Segal et al., 2003; Galvez and Greenough, 2005; Koekkoek et al., 2005; McKinney et al., 2005; Antar
et al., 2006; Grossman et al., 2006, 2010; Dictenberg et al., 2008; Cruz-Martin et al., 2010; Pan et al., 2010;
Levenga et al., 2011a; Qin et al., 2011; Berman et al., 2012; He and Portera-Cailliau, 2013; Amiri et al., 2014;
Wijetunge et al., 2014
MECP2 Fukuda et al., 2005; Zhou et al., 2006; Chapleau et al., 2009; Nguyen et al., 2012; Stuss et al., 2012; Jiang
et al., 2013a; Baj et al., 2014
UBE3A Dindot et al., 2008; Greer et al., 2010; Yi et al., 2015; Kim et al., 2016; Valluy et al., 2015
TSC1/2 Tavazoie et al., 2005
plasticity, and long-term stability of these structures (Matus,
2000; Matus et al., 2000; Luo, 2002; Lin and Webb, 2009;
Korobova and Svitkina, 2010; Lin and Koleske, 2010; Svitkina
et al., 2010; Dent et al., 2011; Nicholson et al., 2012; Penzes
and Cahill, 2012; Penzes and Rafalovich, 2012; Saneyoshi and
Hayashi, 2012).
Actin and Microtubule Regulators Are
Associated with Autism
Myosins are motors that utilize ATPase activity to provide
motility of actin or cargo transport on actin filaments (Pollard
and Korn, 1973; Oliver et al., 1999; Tyska and Warshaw,
2002). Several myosin isoforms play central roles in regulating
neurite outgrowth, as well as dendritic spine structural plasticity
(Wylie et al., 1998; Wylie and Chantler, 2003; Ryu et al.,
2006; Hammer and Wagner, 2013; Kneussel and Wagner,
2013; Yoshii et al., 2013; Koskinen et al., 2014; Ultanir et al.,
2014). Among all isoforms, MYO16 (Myr8 or NYAP3) was
recently implicated in ASD (Wang et al., 2009; Connolly
et al., 2013; Kenny et al., 2014; Roberts et al., 2014; Liu
et al., 2015b). MYO16 is expressed predominantly in the
cortex and cerebellum. Levels and phosphorylation of MYO16
protein peak during early developmental stages, consistent
with a role in regulating neuronal migration and neurite
extension (Patel et al., 2001; Yokoyama et al., 2011). In addition
to binding directly to filamentous- (F-)actin, MYO16 also
physically interacts with PI3K and WAVE complex to regulate
stress fiber remodeling in fibroblasts as well as the adhesion-
dependent neurite outgrowth in neurons (Yokoyama et al.,
2011).
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TABLE 3 | Summary of autism-associated genes that regulate synaptic plasticity.
Functional category Gene Representative references
Cytoskeletal regulator
SYNGAP1 Vazquez et al., 2004; Rumbaugh et al., 2006; Carlisle et al., 2008; Clement et al., 2012, 2013; Ozkan et al.,
2014
Adhesion molecule
CDHs Bozdagi et al., 2000; Manabe et al., 2000; Togashi et al., 2002; Bozdagi et al., 2010; Mendez et al., 2010
NRXN Levinson et al., 2005; Etherton et al., 2009
NLGN Chih et al., 2005; Varoqueaux et al., 2006; Chubykin et al., 2007; Tabuchi et al., 2007
Surface receptor
GRIN2B Brigman et al., 2010; Ohno et al., 2010; Wang et al., 2011a; Yang et al., 2012a; Ryan et al., 2013; Dupuis
et al., 2014
GRIK2/4 Contractor et al., 2001; Huettner, 2003; Youn and Randic, 2004; Lanore et al., 2012; Aller et al., 2015
Signaling molecule
CDKL5 Della Sala et al., 2016
PTEN Fraser et al., 2008; Luikart et al., 2011
Synaptic protein
SHANK3 Bangash et al., 2011; Peça et al., 2011; Wang et al., 2011b; Peixoto et al., 2016
DLGAP2 Jiang-Xie et al., 2014
STXBP5 Barak et al., 2013; Ben-Simon et al., 2015
Syndromic disorder related gene
FMR1 Segal et al., 2003; Koekkoek et al., 2005; Bureau et al., 2008; Auerbach and Bear, 2010
MECP2 Collins et al., 2004; Dani et al., 2005; Asaka et al., 2006; Moretti et al., 2006; Chao et al., 2007; Zhang
et al., 2008; Cohen et al., 2011; Li et al., 2011; Noutel et al., 2011; Blackman et al., 2012; Na et al., 2012;
Qiu et al., 2012; Zhong et al., 2012; Na et al., 2013; Della Sala and Pizzorusso, 2014; Deng et al., 2014; De
Filippis et al., 2015
UBE3A Yashiro et al., 2009; Sato and Stryker, 2010; Smith et al., 2011; Hayrapetyan et al., 2014
CTTNBP2 encodes cortactin-binding protein 2 that interacts
with cortactin, a nucleation-promoting factor of actin (Ohoka
and Takai, 1998). CTTNBP2 is highly expressed in dendritic
spines where it locally interacts with cortactin, striatin, a
calcium binding protein, and PP2A, a serine/threonine protein
phosphatase 2A, to control the formation and the maintenance
of dendritic spines (Chen et al., 2012; Chen and Hsueh, 2012;
Hsueh, 2012). In addition, oligomerization of CTTNBP2 induces
microtubule bundling to promote dendrite arborization (Shih
et al., 2014). Several mutations of CTTNBP2 have been reported
in ASD cases, further indicating the importance of neurite
outgrowth and dendritic spine formation for proper brain
function (Cheung et al., 2001; Iossifov et al., 2012; De Rubeis et al.,
2014).
Activity-dependent neuroprotective protein (ADNP) is a
homeobox-containing protein secreted from glia and neurons
(Bassan et al., 1999; Zamostiano et al., 2001; Furman et al.,
2004; Mandel et al., 2008; Nakamachi et al., 2008). Through its
interaction with the chromatin remodeling complex SWI/SNF,
ADNP regulates hundreds of genes to modulate brain function
(Pinhasov et al., 2003; Mandel and Gozes, 2007; Mandel
et al., 2007). In addition to its traditional role in regulating
transcription, ADNP has also been suggested to have function
in regulating dendritic spines through interactions with
microtubule end binding proteins (Oz et al., 2014). Mutations
in or the alteration of the protein expression of ADNP have
been associated with several neurological disorders, including
schizophrenia and Alzheimer’s Disease (Vulih-Shultzman et al.,
2007; Fernandez-Montesinos et al., 2010; Dresner et al., 2011;
Yang et al., 2012b). Intriguingly, the association of mutations
in ADNP and ASD is further emphasizing that the cytoskeletal
integrity of neurons is vulnerable in ASD (O’Roak et al.,
2012a,b; Ben-David and Shifman, 2013; De Rubeis et al., 2014;
Helsmoortel et al., 2014; Vandeweyer et al., 2014; D’Gama et al.,
2015).
Small RhoGTPase Regulation Is a Key
Mechanism in Controlling Neurite and
Spine Stability
Small RhoGTPases including Rho, Rac, and Cdc42 are central
cytoskeletal regulators that control cell motility and morphology
(Govek et al., 2005; Newey et al., 2005; Lin and Koleske,
2010; Tolias et al., 2011). Genetic mutations or dysregulation
of the small RhoGTPase regulators, including guanine-exchange
factors (GEFs) and GTPase-activating proteins (GAPs), have
been implicated in several neurological conditions, including
ASD (Newey et al., 2005; Lin and Koleske, 2010; Antoine-
Bertrand et al., 2011; Stankiewicz and Linseman, 2014). Here, we
will highlight those that regulate the morphological stability of
neurons.
Engulfment and cell motility 1 (ELMO1) was first identified in
a complex with a RacGEF, DOCK180, to activate Rac1 activity,
which is essential for cell migration and phagocytosis (Gumienny
et al., 2001; Brugnera et al., 2002; Grimsley et al., 2004). In
hippocampal neurons, ELMO1 and DOCK180 colocalize at
synaptic sites and together are required for spine formation
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FIGURE 2 | Schematic illustration of how autism-risk genes regulate neuronal structure and their sites of action. An illustration of a dendritic segment
containing a dendrite and a dendritic spine is enlarged from the box region on the left and shown on the right. Microtubules (green) and actin filaments (blue) are two
major cytoskeletons found in dendrites and dendritic spines, respectively. Autism-risk genes (in bold font) are categorized by their main function and color coded
accordingly. (1) Cytoskeletal proteins (gray rounded rectangular box): MYO16, CTTNBP2, and ADNP, directly regulate actin and microtubule function to control
dendritic spine and neurite stability. ELMO1 and SYNGAP1 regulate actin dynamics to control spine stability via small RhoGTPases. (2) Adhesion molecules (colored
rectangular box): Cadherins (CDHs), protocadherins (PCDHs), and neurexin (NRXN)-neuroligin (NLGN) complex, as well as surface receptors, NTRK, GRIK, and
NMDAR, act at synapses to regulate synaptic function. NCAM2 and CNTNAP2, also have functions in regulating neurite outgrowth. (3) Signaling molecules (blue
ellipse shape): CDKL5, DYRK1A, and PTEN regulate several signaling pathways to maintain the stability of dendritic structures. (4) Scaffolding proteins (yellow
polygon): SHANK3 and DLGAP2, locate at post-synaptic density and tightly associate with PSD95 and other signaling molecules to regulate spine stability and
synaptic plasticity. (5) Synaptic proteins (pink ellipse shape): STXBP5 and PRICKLE1 not only regulate synaptic vesicle release, but also play a role in regulating
neurite outgrowth. (6) Syndromic molecules (clear rectangular box): FMRP and UBE3A regulate the structural stability of neurons via the regulation of protein
synthesis or binding with other molecules in dendritic spines. MECP2 mainly functions in the nucleus and regulates transcription of many genes to in turn affecting
the structural stability of neurons. TSC1/2 regulates the mTOR pathway and cytoskeletal machinery to maintain dendritic stability.
(Kim et al., 2011a). Loss of Elmo1 shows a reduction in
spine number but increased filopodia, suggesting a role in
formation and/or maintenance of mature spines (Kim et al.,
2011a). In addition, ELMO1 has been shown to regulate axonal
and dendritic branching via Rac1 activation in response to
different upstream signals (Franke et al., 2012; Lanoue et al.,
2013).
SYNGAP1 encodes a synaptic-specific Ras/Rap GAP that
associates with PSD-95 and specifically localizes to synaptic
sites (Kim et al., 1998; Krapivinsky et al., 2004). The role of
SYNGAP1 in regulating spine morphology and synaptic function
has been well described. In response to CaMKII phosphorylation,
SYNGAP1 directly regulates Ras/Rap activity to modulate MAPK
signaling to maintain the stability of dendritic spines (Chen
et al., 1998; Krapivinsky et al., 2004; Oh et al., 2004; Rumbaugh
et al., 2006). Overexpression of SYNGAP1 decreases AMPAR-
mediated currents and surface expression (Rumbaugh et al.,
2006; Wang et al., 2013). Deletion or reduction of SYNGAP1
results in an elevated synaptic strength and an increase of
mushroom spines (Vazquez et al., 2004; Rumbaugh et al., 2006;
Carlisle et al., 2008). Mice with Syngap1 haploinsufficiency
show accelerated maturation of dendritic spines followed by
disruptions of synaptic transmission and cognitive function
(Clement et al., 2012, 2013; Ozkan et al., 2014; Aceti et al.,
2015). Coincidentally, haploinsufficiency in SYNGAP1 has been
found in individuals with autism, intellectual disability, and a
specific form of epilepsy (Berryer et al., 2013). Several other
de novo mutations of SYNGAP1 also have been identified
in different cases of ASD (Pinto et al., 2010; Cook, 2011;
Hamdan et al., 2011; Berryer et al., 2013; Willsey et al., 2013;
Brett et al., 2014; De Rubeis et al., 2014; O’Roak et al.,
2014).
Since the actin and microtubule cytoskeletons are the major
components of neuronal processes, it is not surprising that
manipulating the cytoskeletal machinery dramatically affects
neuronal structures. A small imbalance of cytoskeletal dynamics
will create a huge impact on the structural stability of neurons,
which in turn alters the formation of neuronal circuitry.
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Interestingly, most autism-associated cytoskeletal regulators
control neurite outgrowth and synapse/spine formation thereby
affecting the structural stability of neurons. These two processes
are also the initial steps to establish correct neuronal connections
during development. Failure to regulate these processes properly
may result in significantly altered wiring of brain circuitries that
is often found in ASD. The next research focus should investigate
early in development to connect the dysregulatory effects of
mutations in cytoskeletal genes.
TRANS-SYNAPTIC ADHESION
MOLECULES PLAY IMPORTANT ROLES
IN THE REGULATION OF NEURONAL
STABILITY
Cell adhesion molecules (CAMs) play crucial roles in many
aspects of neural circuit formation and, thus, it comes as no
surprise that these molecules are found as top hits in lists of
autism risk genes (Betancur et al., 2009; Pinto et al., 2010;
Hussman et al., 2011; Chen et al., 2014b). Here, we discuss
the current understanding of how CAMs that belong to the
cadherin-, the neurexin/neuroligin- and the immunoglobulin-
superfamily regulate neuronal stability.
Cadherin Superfamily Members Are
Prominent Hits in Autism Risk Gene Lists
The genetic association of cadherins with autism strongly
supports their central roles in the development of the nervous
system including synaptogenesis, dendrite arborization and
dendritic spine regulation (Arikkath and Reichardt, 2008; Suzuki
and Takeichi, 2008; Basu et al., 2015; Friedman et al., 2015a;
Seong et al., 2015). The cadherin superfamily is comprised
of more than a hundred different genes, subdivided into
several classes including classical cadherins, protocadherins and
atypical cadherins (Hulpiau and van Roy, 2009; Hirano and
Takeichi, 2012). Several copy number variations (CNVs) and
single nucleotide polymorphisms (SNPs) are found in classical
cadherins: CDH2, CDH5, CDH8, CDH9, CDH10, CDH11, and
CDH13 (Wang et al., 2010; Chapman et al., 2011; Hussman
et al., 2011; Pagnamenta et al., 2011; Sanders et al., 2011;
O’Roak et al., 2012b; Prandini et al., 2012; Connolly et al.,
2013; Walker and Scherer, 2013; Crepel et al., 2014; Krumm
et al., 2015); non-clustered protocadherins: PCDH9, PCDH10,
and PCDH19 (Morrow et al., 2008; Depienne et al., 2009;
Camacho et al., 2012; O’Roak et al., 2012b; Prasad et al., 2012;
Girirajan et al., 2013; van Harssel et al., 2013); and an atypical
cadherin, FAT1 (Hussman et al., 2011; Neale et al., 2012; Cukier
et al., 2014; Kenny et al., 2014). In general, the extracellular
domain of cadherins contains five cadherin repeats/EC motifs
that mediate Ca2+-dependent homophilic adhesion (Tanihara
et al., 1994). However, heterophilic interactions between different
sub-classes of classical cadherins create more combinations
of interaction and function (Shimoyama et al., 2000). The
cytosolic tail binds to catenins leading to the anchoring
of the cadherin-catenin complex to the cytoskeleton (via
β-catenin and α-catenin) and the clustering of cadherins in
the plasma membrane (via p120-catenin) (Yap et al., 1998;
Nelson, 2008; McCrea and Gu, 2010). The cadherin superfamily
contains numerous cadherin members which impact neuronal
structure and function from early neurite extension to the
maintenance of mature synaptic networks (Basu et al., 2015;
Friedman et al., 2015a). However, the pathways underlying
disrupted cadherin signaling still requires further investigation.
Here, we focus our discussion on the autism-associated
cadherins shown to regulate neurite outgrowth and synapse
morphogenesis.
N-cadherin, also known as cadherin 2 (CDH2), is the best
studied classical cadherin. N-cadherin functions throughout
the development of the nervous system, including neurite
outgrowth, axon guidance, synaptogenesis and synaptic plasticity
(Takeichi and Abe, 2005; Arikkath and Reichardt, 2008; Hirano
and Takeichi, 2012; Friedman et al., 2015a). N-cadherin
promotes dendritic outgrowth during development and is also
required for activity-dependent dendrite expansion (Esch et al.,
2000; Tan et al., 2010). N-cadherin is also required for the
establishment of initial contacts between axons and filopodia
followed by clustering at contact points to stabilize early
synapses (Benson and Tanaka, 1998; Huntley and Benson,
1999; Togashi et al., 2002). Blocking N-cadherin adhesion
in hippocampal neurons perturbs synapse formation and
abolishes long-term potentiation (LTP)-induced stabilization
of dendritic spines (Togashi et al., 2002; Mendez et al.,
2010). Neural activity increases N-cadherin protein levels and
dimerization leading to increased synapse number (Bozdagi
et al., 2000). In mature synapses, N-cadherin is required
for the persistence of dendritic spine enlargement and LTP
(Bozdagi et al., 2000, 2010). Together with N-cadherin,
CDH8 regulates the development of the hippocampal mossy
fiber pathway (Bekirov et al., 2008). CDH8 also mediates
assembly and maturation of corticostriatal synapses (Bekirov
et al., 2008; Friedman et al., 2015b), whereas CDH9-mediated
adhesion is involved in the formation and differentiation
of dentate gyrus synapses on CA3 cells where it regulates
synapse density, presynaptic bouton complexity and postsynaptic
morphology (Williams et al., 2011). In contrast to CDH8
and CDH9, an RNAi screen for molecules required for
synapse development identified CDH11 and CDH13 as positive
regulators of glutamatergic synapse development (Paradis et al.,
2007). Interestingly, Cdh11-deficient mice revealed enhanced
LTP in the CA1 region of the hippocampus and mice show
reduced fear- or anxiety-related behavior suggesting that CDH11
might restrict synaptic plasticity and efficacy (Manabe et al.,
2000).
Protocadherins are the largest subgroup within the cadherin
superfamily and are further subtyped into clustered (α-,
β- and γ-PCDH) and non-clustered protocadherins (δ1-
and δ2-PCDH) (Frank and Kemler, 2002). They share a
similar structure to classical cadherins, but with six to seven
cadherin domains/EC motifs. However, the cytosolic tails
of protocadherins and cadherins do not show significant
homology suggesting that they likely engage distinct intracellular
signaling pathways. Protocadherins are highly expressed in
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the nervous system and localize to synapses. Based on their
spatial and temporal expression pattern in the brain and
on recent reports, protocadherins have roles in dendritic
development and synaptic connections (Hirano et al., 1999;
Frank and Kemler, 2002; Kim et al., 2007, 2011b; Keeler
et al., 2015). For example, PCDH10 expression is regulated by
neuronal activity and its function is crucial for forebrain axon
outgrowth and the proper patterning of thalamocorticial
projections (Uemura et al., 2007; Morrow et al., 2008).
In addition, PCDH10 mediates synapse elimination by
promoting proteasomal degradation of PSD-95 (Tsai et al.,
2012a).
FAT atypical cadherin 1 (FAT1) belongs to the atypical
cadherin family and consists of a huge extracellular domain
comprising 34 cadherin domains/EC motifs (Tanoue and
Takeichi, 2005; Sadeqzadeh et al., 2014). FAT1 expression
is enriched during embryonic neurodevelopment and severe
nervous system defects are found in FAT1-deficient mice
(Ciani et al., 2003; Sadeqzadeh et al., 2014). At the cellular
level, FAT1 localizes to cell–cell contacts as well as to the
leading edge of lamellipodia and tips of filopodia to regulate
cell polarity, cell migration, and cell-cell adhesion (Moeller
et al., 2004; Tanoue and Takeichi, 2004). These functions are
likely mediated through intracellular signaling via Ena/VASP
proteins to regulate actin assembly and dynamics (Moeller
et al., 2004; Tanoue and Takeichi, 2004). Other intracellular
binding partners of FAT1 include the classical cadherin
binding partner β-catenin as well as the synaptic scaffolding
molecules Homer-1 and 3 (Hou et al., 2006; Schreiner et al.,
2006).
The Neurexin-Neuroligin Complex Is One
of the Most Studied Trans-synaptic
Adhesion Pairs in Autism
Neurexins are encoded by three genes (NRXN1-3) while the
neuroligin family consists of four isoforms in mice (Nlgn1-4)
and five isoforms in humans (NLGN1-4X and 4Y) (Südhof,
2008). Neurexins localize to presynaptic terminals and form
heterophilic interactions with neuroligins, which are localized
to the postsynaptic compartment (Ichtchenko et al., 1995, 1996;
Nguyen and Sudhof, 1997). Presynaptic neurexins link synaptic
adhesion with the synaptic vesicle release machinery via binding
to PDZ-domain containing proteins (Hata et al., 1996; Butz et al.,
1998; Dean et al., 2003; Missler et al., 2003). At the postsynaptic
site, the neurexin-neuroligin complex induces clustering of
scaffolding proteins, such as PSD-95, and recruits NMDA- and
AMPA-receptors (Irie et al., 1997; Chih et al., 2005; Nam and
Chen, 2005; Heine et al., 2008; Barrow et al., 2009; Mondin et al.,
2011). Distinct neurexin-neuroligin complexes play discrete roles
during synaptogenesis with neuroligin-1 regulating excitatory
synapse formation and maturation, while neuroligin-2 and
3 mediate inhibitory synapse formation (Song et al., 1999;
Scheiffele et al., 2000; Prange et al., 2004; Varoqueaux et al.,
2004, 2006; Chih et al., 2005; Levinson et al., 2005; Barrow et al.,
2009; Kwon et al., 2012; Gokce and Sudhof, 2013). Intriguingly,
neurexin-1 can also bind to leucine-rich repeat transmembrane
protein 2 (LRRTM2) and promote synapse formation (de Wit
et al., 2009; Ko et al., 2009; Gokce and Sudhof, 2013). In
addition to their synaptic roles, interaction of neurexin-1 and
neuroligin-1 regulates neurite outgrowth (Gjorlund et al., 2012).
Several mutations and CNVs in NRXN1-3 have been found to be
associated with ASD with the prevalence highest for mutations in
NRXN1 (Feng et al., 2006; Autism Genome Project Consortium
et al., 2007; Kim et al., 2008; Yan et al., 2008; Ching et al., 2010;
Pinto et al., 2010; Wisniowiecka-Kowalnik et al., 2010; Gauthier
et al., 2011; Voineskos et al., 2011; Camacho-Garcia et al., 2012;
Duong et al., 2012; Iossifov et al., 2012; Kong et al., 2012; Liu
et al., 2012; Prasad et al., 2012; Schaaf et al., 2012; Vaags et al.,
2012; Bena et al., 2013; Dabell et al., 2013; Girirajan et al., 2013;
Jiang et al., 2013b; Koshimizu et al., 2013; Walker and Scherer,
2013; Cukier et al., 2014; De Rubeis et al., 2014; Egger et al.,
2014; Imitola et al., 2014; Vinas-Jornet et al., 2014; Tammimies
et al., 2015). Similarly, NLGN1-4 genes have been implicated in
the pathogenesis of ASD with NLGN3 and 4 being the most
prevalent (Jamain et al., 2003; Laumonnier et al., 2004; Ylisaukko-
oja et al., 2005; Lawson-Yuen et al., 2008; Glessner et al., 2009;
Yu et al., 2011, 2013; Leblond et al., 2012; O’Roak et al., 2012b;
Steinberg et al., 2012; Yanagi et al., 2012; Girirajan et al., 2013;
Jiang et al., 2013b; Iossifov et al., 2014; Kenny et al., 2014; Li et al.,
2014a; Krumm et al., 2015; Sanders et al., 2015; Yuen et al., 2015).
However, several reports also indicate the negative association of
NLGN3 and 4 with autism (Vincent et al., 2004; Gauthier et al.,
2005; Blasi et al., 2006; Wermter et al., 2008; Avdjieva-Tzavella
et al., 2012; Liu et al., 2013b; Xu et al., 2014). Further investigation
is required to clarify this controversy.
Mutations in another member of the neurexin superfamily,
contactin-associated protein-like 2 (CNTNAP2/CASPR2), have
also been identified in individuals with autism (Alarcón et al.,
2008; Arking et al., 2008; Bakkaloglu et al., 2008; Vernes et al.,
2008; Li et al., 2010; Petrin et al., 2010; Poot et al., 2010; Nord
et al., 2011; O’Roak et al., 2011; Peñagarikano et al., 2011;
Whitehouse et al., 2011; Anney et al., 2012; Prasad et al., 2012;
Girirajan et al., 2013; Sampath et al., 2013; Egger et al., 2014; Poot,
2014; Chiocchetti et al., 2015). CNTNAP2 is required for dendrite
arborization and dendritic spine development and maintenance
(Anderson et al., 2012; Gdalyahu et al., 2015). Mice deficient for
Cntnap2 show defects in spine stabilization and synaptic function
resulting in several core ASD-like behaviors such as deficits
in communication and social interaction, as well as repetitive
behaviors (Peñagarikano et al., 2011; Gdalyahu et al., 2015; Varea
et al., 2015).
Immunoglobulin Superfamily of Cell
Adhesion Molecules Participate Largely
in Neuronal Circuit Formation
The immunoglobulin superfamily of CAMs (IgSF-CAMs),
including contactin, L1CAM, NCAM or SynCAM, make up
a third large group of trans-synaptic CAMs. IgSF-CAMs have
been implicated in various processes during neural circuit
formation, from neurite outgrowth and axonal navigation
to synapse formation and plasticity (Rougon and Hobert,
2003).
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The contactin (CNTN) subfamily consists of six members
(CNTN1-6), each of which contain six Ig-like and four
fibronectin III-like domains that are linked to the cell
membrane via a glycosylphosphatidylinositol (GPI)-anchoring
domain (Shimoda and Watanabe, 2009). While CNTN1 and
2 have been extensively studied in the context of neurite
outgrowth, fasciculation, and axon guidance, less is known about
the function of CNTN3-6 (Karagogeos, 2003; Shimoda and
Watanabe, 2009; Mohebiany et al., 2014). However, CNTN3-6
have been implicated as risk genes in ASD (Fernandez et al.,
2004; Christian et al., 2008; Morrow et al., 2008; Glessner et al.,
2009; Roohi et al., 2009; Cottrell et al., 2011; Hussman et al.,
2011; van Daalen et al., 2011; Leblond et al., 2012; Prasad
et al., 2012; Vaags et al., 2012; Cukier et al., 2014; Kashevarova
et al., 2014; Nava et al., 2014; Poot, 2014; Hu et al., 2015;
Liu et al., 2015a). CNTN4 is strongly expressed in a subset of
olfactory sensory neurons where it guides proper targeting of
axon terminals to the corresponding glomeruli for the formation
of olfactory circuits (Kaneko-Goto et al., 2008). The Cntn5
knockout mice display reduced fiber density and glutamatergic
synapses in the auditory brainstem (Li et al., 2003; Toyoshima
et al., 2009). CNTN6 is highly expressed in the postnatal
cerebellum and plays an important role in the formation of
synapses between parallel fibers and Purkinje cells (Takeda
et al., 2003; Sakurai et al., 2009). Similarly, CNTN6 regulates
the formation of glutamatergic synapses in the hippocampus
and the orientation of apical dendrites of layer V pyramidal
neurons in the visual cortex (Ye et al., 2008; Sakurai et al.,
2010).
Neural cell adhesion molecule 2 (NCAM2) belongs to the
NCAM family and is a paralog of NCAM1. Similar to other
members of the Ig-superfamily, NCAMs contain five Ig- and two
FN3-domains in the extracellular region and are differentially
spliced to produce both transmembrane and GPI-anchored
variants (Winther et al., 2012). NCAM2 is predominantly
expressed in the brain and required for the formation and
maintenance of axonal and dendritic compartmentalization in
the olfactory glomeruli (Walz et al., 2006; Borisovska et al., 2011).
In addition, NCAM2 regulates filopodia formation and neurite
branching of cortical neurons via a CaMKII-dependent signaling
pathway (Sheng et al., 2015). SNP and chromosomal deletion
including NCAM2 has been reported in individuals with autism
(Haldeman-Englert et al., 2010; Hussman et al., 2011; Petit et al.,
2015).
Adhesion molecules are a huge group of proteins that
display many similarities in molecular structure and in
signaling property. Depending on the cellular localization,
functions of adhesion molecules range from neurite outgrowth
and synapse/spine formation, to neuronal plasticity, further
highlighting their importance in regulating the structural
stability of neurons. However, whether these molecules
function to compensate each other or are developmentally
regulated is still not clear. The interesting question is
whether the temporal and spatial expression patterns of
these autism-associated adhesion molecules correlate with the




PATHWAYS TO REGULATE NEURONAL
STABILITY
Establishment of synaptic connections and modification of
their strength and stability is intimately related to the
receptor populations in the plasma membranes of pre- and
postsynaptic cell compartments. Thus, several ASD risk genes
code for cell surface receptor proteins including the ionotropic
glutamate receptors (iGluR) and the receptor tyrosine kinases
(RTK).
Glutamate Receptors: GRIN2B and the
GRIK Genes
Glutamate-mediated ionotropic signaling occurs via activation
of the glutamate-gated ion channel family which is divided
into three subfamilies; the α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs), the N-methyl-D-
aspartate receptors (NMDARs) and the kainate-type receptors
(KARs) (Collingridge et al., 2009). The main function of these
receptors focuses on the regulation of synaptic activity and
plasticity, which in turn affect the structural stability of neurons.
In particular, the genetic association of the GRIN2B gene, which
encodes the GluN2B subunit of NMDARs, and the GRIK2/4
genes that encodes the GluK2 and 4 subunits of KARs with autism
has been established (Jamain et al., 2002; Shuang et al., 2004;
Holt et al., 2010; Myers et al., 2011; O’Roak et al., 2011, 2012a;
Tarabeux et al., 2011; de Ligt et al., 2012; Griswold et al., 2012;
Prasad et al., 2012; Talkowski et al., 2012; Yoo et al., 2012; Dimassi
et al., 2013; De Rubeis et al., 2014; Kenny et al., 2014; Li et al.,
2014a; Namjou et al., 2014; Poot, 2014; Aller et al., 2015; Pan et al.,
2015).
NMDARs are composed of an obligatory GluN1 subunit
and one or more GluN2 (GluN2A-GluN2D) subunits with
the majority of the composition being GluN1/2A/2B (Buller
et al., 1994; Petralia et al., 1994; Luo et al., 1997). The
composition of GluN2 subunits are developmentally regulated
and critically determine the synaptic properties (Laurie and
Seeburg, 1994; Sheng et al., 1994; Li et al., 1998). The GluN2B
subunit expresses early during development gradually being
replaced by GluN2A indicating its role in the formation of
neuronal circuitry (Sheng et al., 1994; Li et al., 1998; Bustos
et al., 2014). Overexpression or knockdown of GluN2B alters
dendrite arborization in neurons both in vivo and in vitro
(Ewald et al., 2008; Espinosa et al., 2009; Sepulveda et al., 2010;
Bustos et al., 2014). GluN2B is also required for the formation
of dendritic spines, maturation of synapses, and the proper
molecular compositions of several postsynaptic proteins (Akashi
et al., 2009; Espinosa et al., 2009; Brigman et al., 2010; Kelsch
et al., 2012). In turn, GluN2B is crucial for maintaining proper
synaptic plasticity (Brigman et al., 2010; Ohno et al., 2010;
Wang et al., 2011a; Yang et al., 2012a; Ryan et al., 2013; Dupuis
et al., 2014). GRIN2B, an autism-risk gene, further suggests
that pathways involved in early circuitry formation may be
vulnerable targets in autism. Selective inhibition of GluN2B
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function has been shown to restore dendritic spine loss and
associated behavior alterations in several experimental conditions
providing insights to the potential therapeutic targets to correct
some ASD phenotypes (Chen et al., 2011; Iafrati et al., 2014;
Gupta et al., 2015).
Kainate-type receptors regulate axonal filopodia motility of
hippocampal mossy fibers in response to neuronal stimulation
during synaptogenesis (Tashiro et al., 2003). KAR subunits,
in particular GluK2, interacts with structural elements of
the synapse; such as the PSD-95 and SAP-102 scaffolding
molecules, as well as the N-cadherin and β-catenin adhesion
molecules (Carta et al., 2014; Pahl et al., 2014), indicating
that Grik genes are involved in processes that regulate synapse
architecture and stability. Indeed, GluK2 regulates hippocampal
synapse maturation and stability (Huettner, 2003; Contractor
et al., 2011; Lanore et al., 2012; Lerma and Marques, 2013).
Animals with deficient GluK2 proteins exhibit a delay in the
postnatal maturation of synaptic contacts between MF-CA3
in the hippocampus, suggesting that the expression of the
GluK2 is important for the establishment of normal morphology
and function of synaptic networks in the hippocampus
(Contractor et al., 2001; Lanore et al., 2012). Expression
of the GluK4 is mainly restricted to mossy fiber synapses
in the hippocampal CA3 region where it co-assembles with
GluK2 in functional pre- and postsynaptic GluK2/4 receptor
complexes (Darstein et al., 2003). Mice with forebrain GluK4
overexpression exhibit altered synaptic transmission and display
several autistic-like behaviors including social impairment,
enhanced anxiety, and depressive states, coinciding with the
finding of GRIK4 duplications in individuals with ASD (Griswold
et al., 2012; Aller et al., 2015). Even though the phenotypes
resulting from Grik gene dysfunction in mice are in the same
general categories with symptoms of ASD, further investigation
about the molecular consequences of impairments in GluK
proteins in ASD is required for developing future therapeutic
interventions.
Receptor Tyrosine Kinases: The NTRK
Genes
Tyrosine receptor kinases (Trks) mediate neurotrophic
growth factor-induced signaling via dimerization and trans-
autophosphorylation of Tyr residues on the intracellular
domains of the receptor and subsequent activation of
intracellular signaling pathways (Deinhardt and Chao,
2014). This results in a number of neurogenic events, such
as synaptic plasticity, maturation and stability, dendritic and
axonal growth and differentiation as well as cell survival and
maintenance (Martinez et al., 1998; Deinhardt and Chao,
2014). The Trk family consists of three proteins; TrkA, B
and C, which are expressed by the neurotrophic tyrosine
receptor kinase genes (NTRK) 1, 2 and 3, respectively.
Each Trk receptor interacts selectively with a different
neurotrophin resulting in preferential interaction pairs:
TrkA is activated by NGF, TrkB by BDNF, and TrkC by
NT-3 (Deinhardt and Chao, 2014). Considering its well-
documented function in synaptophysiology (Minichiello,
2009), it would be reasonable to suspect a correlation between
genetic variations in NTRK2 and ASD. However, to date, only
one study has reported a weak association between NTRK2
mutations and ASD (Correia et al., 2010), while other studies
were unable to confirm that link (Chakrabarti et al., 2009).
Alternatively, a growing body of evidence generated from
genetic evaluation of ASD risk genes has identified NTRK3,
the gene coding for TrkC, as a plausible candidate in autism
(Chakrabarti et al., 2009; Hussman et al., 2011; Vardarajan et al.,
2013).
In the mammalian brain, TrkC (as well as other neurotrophic
receptors) is present both as full length catalytically active
receptor, as well as a splice variant that lacks the Tyr kinase
domain and is catalytically inactive (Ichinose and Snider,
2000). Interestingly, knockout of the non-catalytic TrkC isoform
in mice yields a more severe phenotype than does the
depletion of the kinase-active receptor, indicating that TrkC
has important functions beyond the ability to convey classical
RTK signaling (Faux et al., 2007; Deinhardt and Chao, 2014).
Indeed, recent studies have begun to elucidate the function
assigned to non-catalytic isoforms by demonstrating a role
for TrkC in synaptic adhesion complexes (Takahashi and
Craig, 2013). Postsynaptic TrkC interacts across the presynaptic
cleft with protein tyrosine phosphatase (PTP) σ to form an
adhesion complex crucial for development and stability of
excitatory, but not inhibitory, synapses (Takahashi et al., 2011;
Coles et al., 2014). Formation of this adhesion complex is
enhanced by the presence of the TrkC ligand, NT-3, which
facilitates glutamatergic presynaptic assembly and function
(Ammendrup-Johnsen et al., 2015). NT-3 binding to kinase
domain-truncated TrkC isoforms has also been shown to induce
cytoskeletal changes via recruitment of the scaffold protein
tamalin, leading to activation of Arf6 and induction of Rac1-
GTP (Esteban et al., 2006). Interestingly, the expression of
non-catalytic TrkC relative to the kinase active isoform is
upregulated during the second and third postnatal weeks,
the most intense period of synaptogenesis, indicating that
expression of the different Ntrk3 gene products is temporally
associated with synapse formation (Valenzuela et al., 1993;
Menn et al., 2000). Recent studies also found that NT-3-TrkC
signaling between presynaptic granule neurons and postsynaptic
Purkinje cells controls dendrite morphogenesis in cerebellum
(Joo et al., 2014). Although no studies have evaluated the
ratio of non-catalytic to catalytic TrkC receptors in individuals
with ASD, it might be speculated that certain genetic variants
could cause imbalances in the expression patterns of NTRK3
isoforms.
Surface receptors respond to extracellular signals such
as neurotransmitters and trophic factors to activate
downstream signaling pathways to diversify the cellular
responses. Each receptor may have a unique signaling
pathway associated with it and therefore, the mutations
on selective receptors provide us with clues about which
signaling pathways may be more susceptible to perturbations
in ASD. Thus, identifying the downstream effectors and
signaling pathways that are affected by these autism-associated
receptor mutants should be an important direction of future
investigation.
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SIGNALING MOLECULES ACTIVELY




kinase 1a (DYRK1A) is one of the isoforms in DYRK family and
is a human homolog of the Drosophila kinase minibrain (MNB)
(Shindoh et al., 1996). DYRK1A was first described as a cadidate
gene for intellectual disability in Down syndrome because of its
location on the “Down syndrome critical region” of chromosome
21 (van Bon et al., 1993; Shindoh et al., 1996; Hammerle et al.,
2003). Interestingly, recent genetic analyses suggest that DYRK1A
is also a risk gene in ASD (Iossifov et al., 2012; O’Roak et al.,
2012a,b; Chen et al., 2014a; Krumm et al., 2014; Redin et al.,
2014; Bronicki et al., 2015; van Bon et al., 2016). Expression
of Dyrk1a in mouse brain is limited to early developmental
periods and can promote neurite formation (Okui et al., 1999;
Hammerle et al., 2003; Gockler et al., 2009). In addition,
DYRK1A phosphorylates N-WASP, a cytoskeletal protein, to
inhibit spine formation in primary hippocampal neurons (Park
et al., 2012). Pyramidal neurons in Dyrk1a+/− mouse cortex
have reduced dendritic branches and dendritic spine density,
which potentially causes the reduced brain size in these mice
(Fotaki et al., 2002; Benavides-Piccione et al., 2005). On the other
hand, overexpression of DYRK1A in mice causes increased spine
density in cortical pyramidal neurons, and these animals show
prefrontal deficits including significant impairment of spatial
learning and cognitive flexbitiliy (Altafaj et al., 2001; Thomazeau
et al., 2014). However, overexpressing DYRK1A in primary
cortical mouse neurons significantly reduces dendrite complexity
through disruption of REST/NRSF levels and REST/NRSF-
SWI/SNF chromatin remodeling complex (Lepagnol-Bestel et al.,
2009).
The Cyclin-dependent kinase-like 5 (CDKL5) is a
serine/threonine kinase, also known as serine/threonine
kinase 9 (STK9). Mutations of CDKL5 have been associated with
several X-linked neurodevelopmental disorders, as well as ASD
(Weaving et al., 2004; Scala et al., 2005; Archer et al., 2006; Russo
et al., 2009; Sprovieri et al., 2009; Schaaf et al., 2011; Bahi-Buisson
and Bienvenu, 2012; Bartnik et al., 2012; Maortua et al., 2012;
Carvill et al., 2013; Epi et al., 2013; Piton et al., 2013; Zhao et al.,
2014; Codina-Sola et al., 2015; Szafranski et al., 2015). Expression
of CDKL5 is enriched in the brain and increases gradually
following development (Lin et al., 2005; Rusconi et al., 2008).
In addition to a catalytic domain, CDKL5 contains nuclear
localization and export signals and can shuttle between the
cytoplasm and nucleus. In the nucleus, CDKL5 phosphorylates
methyl-CpG-binding protein 2 (MECP2), a causative gene for
Rett syndrome (see below), providing a suggestive molecular
mechanism associated with the condition (Mari et al., 2005). In
the cytosol, CDKL5 postively regulates neurite outgrowth and
dendritic arborization via binding with Rac1 (Chen et al., 2010b).
With this broad influence on neuronal function, Cdkl5 null mice
have several defects ranging from neuronal survival, dendritie
maturation, spine stability, synaptic plasticity, and behaviors
(Amendola et al., 2014; Fuchs et al., 2014; Della Sala et al., 2016).
Treatment of Cdkl5 null mice with insulin-like growth factor 1
(IGF-1) or the glycogen synthase kinase 3β (GSK3β) inhibitor
can rescue these defective phenotypes (Della Sala et al., 2016;
Fuchs et al., 2015). Furthermore, CDKL5 has been shown to bind
to palmitoylated-PSD-95 and this interaction is important for
synaptic targeting of CDKL5 and spine formation (Zhu et al.,
2013).
Phosphatase: PTEN
Phosphatase and tensin homolog (PTEN) is a dual-specificity
lipid/protein tyrosine phosphatase that negatively regulates the
phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of
the rapamycin (mTOR) pathway to control cellular function
(Maehama and Dixon, 1998, 1999; Stambolic et al., 1998; Vazquez
and Sellers, 2000; Downes et al., 2001; Leslie and Downes,
2002; Hoeffer and Klann, 2010). PTEN was first identified as
a tumor suppressor (Li et al., 1997) but later also found to be
associated with neurodevelopmental conditions such as epilepsy,
macrocephaly, and autism (Goffin et al., 2001; Butler et al., 2005;
Buxbaum et al., 2007; Orrico et al., 2009; Varga et al., 2009;
McBride et al., 2010; Redfern et al., 2010; Stein et al., 2010;
Schaaf et al., 2011; O’Roak et al., 2012b; Busa et al., 2013; De
Rubeis et al., 2014; Hobert et al., 2014; Marchese et al., 2014;
Vanderver et al., 2014; Codina-Sola et al., 2015; D’Gama et al.,
2015; Johnston and Raines, 2015; Krumm et al., 2015; Spinelli
et al., 2015; Tammimies et al., 2015; Cupolillo et al., 2016;
Schwerd et al., 2016; Tilot et al., 2016). PTEN expression in
the brain is positively correlated with the developmental stages
of neuronal dendrite formation and synaptogenesis suggesting
a role in regulating neuronal function (Perandones et al.,
2004). PTEN plays a critical role in regulating the stability of
dendritic spines and synaptic activity. PTEN overexpression in
hippocampal CA1 pyramidal neurons results in a decrease in
spine density (Zhang et al., 2012). Deleting PTEN in cortical
and hippocampal neurons causes loss of neuronal polarity and
general neuronal hypertrophy, including increases in dendrite
arborization and spine density (Jaworski et al., 2005; Kwon et al.,
2006; Fraser et al., 2008; Zhou et al., 2009). Selective deletion
of PTEN in dentate granule neurons results in increased spine
density and synaptic activity, as well as increased mossy fiber
sprouting (Luikart et al., 2011; Pun et al., 2012). Knockdown of
PTEN in basaolateral amygdala and dentate gyrus, however, does
not affect spine density, but spine morphology is dramatically
altered with an increase of mature mushroom-shaped spines
(Haws et al., 2014). The Pten knockout in cerebellum also
results in significant alterations in neuronal morphology of
Purkinje cells including swelling of dendrites, and an increase
of axonal bouton and dendritic spine size (Cupolillo et al.,
2016). The impact of PTEN on spine stability is dependent on
the phosphorylation status of its serine/threonin residues and
the PDZ-binding motif in its C-terminus (Zhang et al., 2012).
The phenotypes observed following PTEN deletion result from
hyperactivation of the PI3K/AKT/mTOR pathway and inhibition
of this molecular pathway is sufficient to rescue these phenotypes
(Jaworski et al., 2005; Kwon et al., 2006; Zhou et al., 2009; Pun
et al., 2012).
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The identification of the vulnerable intracellular signaling
pathways will aid us in the pursuit to find new therapeutic drug
targets in patients with ASD. Interestingly, a variety of gene
mutations result in disruption of the mechanistic pathways that
these signaling molecules participate in. Therefore, several of
the experimental pharmacological agents currently proposed as
possible treatment strategies for autistic phenotypes are targeting
these signaling molecules (see “Perspectives”).
SYNAPTIC PROTEINS REGULATE
SYNAPTIC FUNCTION TO MAINTAIN
NEURONAL STABILITY
Scaffolding Proteins Provide Supporting
Roles to Connect Structural and
Signaling Molecules
Synaptic signaling processes are key to proper neural function.
Some pivotal components of synapses are postsynaptic
scaffolding proteins, which cluster neurotransmitter receptors,
cell adhesion proteins, ion channels and cytoskeletal molecules to
a confined postsynaptic region (Kim and Sheng, 2004; Sheng and
Hoogenraad, 2007). Dysfunction in scaffolding proteins often
has a huge impact on neuronal function, including neuronal
morphology and synaptic plasticity (Ting et al., 2012). Emerging
evidence has recently linked ASD with mutations of several genes
encoding scaffolding proteins as described below.
SHANK genes encode three large scaffolding proteins,
SHANK1-3, that contain ankyrin repeats, the SH3 domain, the
PDZ domain, the proline-rich domain, and the SAM domain
(Naisbitt et al., 1999; Sheng and Kim, 2000; Baron et al., 2006).
These multiple putative protein interaction domains enable
shank proteins to function as a bridge linking inotropic glutamate
receptors, PSD-95, SAPAPS (Naisbitt et al., 1999), Homers (Tu
et al., 1999; Hayashi et al., 2009) and the cytoskeleton (Böckers
et al., 2001; Qualmann et al., 2004). Altered function of all three
SHANK genes have been implicated in autism, with SHANK3
showing the highest prevalence (Moessner et al., 2007; Gauthier
et al., 2009; Awadalla et al., 2010; Berkel et al., 2010, 2012;
Pinto et al., 2010; Schaaf et al., 2011; Waga et al., 2011; Leblond
et al., 2012, 2014; Prasad et al., 2012; Sanders et al., 2012; Sato
et al., 2012; Boccuto et al., 2013; Koshimizu et al., 2013; Coe et al.,
2014; De Rubeis et al., 2014; Guilmatre et al., 2014; Li et al., 2014a;
Cochoy et al., 2015; Krumm et al., 2015; Nemirovsky et al., 2015;
Yuen et al., 2015). In general, SHANK2 and 3 promote dendritic
spine formation, whereas SHANK1 promotes dendritic spine
head size enlargement (Sala et al., 2001; Roussignol et al., 2005;
Hung et al., 2008; Verpelli et al., 2011). SHANK3 also binds to a
synaptic scaffold, Densin-180, to inhibit the Densin-180-induced
dendrite arborization (Quitsch et al., 2005). Disruption of the
SHANK3 gene is associated with the 22q13.3 deletion syndrome,
characterized by severe expressive-language delay and mild
cognitive challenges (Bonaglia et al., 2001). Several genetically
manipulated Shank3 mutant mouse models were developed to
study the role of SHANK3 mutations in ASD (Bangash et al.,
2011; Peça et al., 2011; Wang et al., 2011b; Jiang and Ehlers, 2013;
Peixoto et al., 2016). Neurons in these mice have morphological
alterations in dendritic spines resulting in LTP deficiency and
defects at striatal synapses. Furthermore, these animals display
several behavioral deficits including abnormal vocalization,
dyadic social interaction, and compulsive-repetitive behaviors.
Intriguingly, re-expressing Shank3 in adulthood is sufficient to
restore parts of the autism-related phenotypes in mice (Mei et al.,
TABLE 4 | Inheritance pattern of autism-risk genes that regulate the structural stability of neurons.
Functional category De novo variants Familial variants
Cytoskeletal regulator CTTNBP2, ADNP, SYNGAP1 CTTNBP2, ADNP, SYNGAP1
Adhesion molecule CDH10, CDH11, PCDH10, PCDH19, FAT1, CTNNA3, NRXN1-3,
NLGN1, NLGN2, NLGN3, CNTNAP2, CNTN4-6
CDH2, CDH8, CDH9, CDH11, PCDH9, PCDH10, PCDH19,
FAT1, CTNNA3, NRXN1, NRXN2, NRXN3, NLGN1, NLGN3,
CNTNAP2, CNTN3, CNTN4, CNTN5-6
Surface receptor GRIK4, NTRK3, GRIN2B GRIK2, NTRK3, GRIN2B
Signaling molecule DYRK1A, CDKL5, PTEN DYRK1A, CDKL5, PTEN
Synaptic molecule SHANK1-3, DLGAP2, STXBP5 SHANK1, SHANK2-3, DLGAP2, STXBP5, PRICKLE1, CYFIP1
Syndromic molecule FMR1, MECP2, UBE3A, TSC2 FMR1, MECP2, UBE3A, TSC1,TSC2
This table shows whether autism-risk variants found in these genes are de novo mutations or familial variants. Most genes have de novo and familial variants, however,
some of genes show a preferential inheritance pattern (underlined; label in bold if only one pattern is found).
TABLE 5 | The common signaling pathways that are altered by mutations of autism-risk genes.
Altered signaling pathway Autism-risk gene involved Available pharmacological agent
mGluR5 SHANK3, FMR1, UBE3A, MECP2 mGluR5 antagonists (e.g., fenobam, mavoglurant, CTEP, MPEP)
PI3K/Akt/mTOR PTEN, MECP2, TSC1/2 mTOR inhibitor (e.g., rapamycin)
IGF-1/GSK3β PTEN, CDK5L, MECP2 IGF-1, GSK3β inhibitor (e.g., SB216763)
Rac1 ELMO1, CDK5L, SHANK3, FMR1 N/A
Several pharmacological agents targeting these pathways are available and have successfully rescued the neuronal phenotype and function experimentally. References
can be found in the text.
Frontiers in Cellular Neuroscience | www.frontiersin.org 12 November 2016 | Volume 10 | Article 263
fncel-10-00263 November 15, 2016 Time: 15:51 # 13
Lin et al. Autism Genes Regulate Neuronal Structures
2016). This study sheds light on the application of gene therapy
for individuals with SHANK3 mutations. Mechanistically, several
actin regulators including Abp1, cortactin, cofilin, and Rac1, have
altered expression or activity associated with Shank3 deficiency
or autism-related mutations that contribute to dendritic spine
reduction and synaptic dystrophy (Haeckel et al., 2008; Durand
et al., 2012; Duffney et al., 2015).
Disks large-associated protein 2 (DLGAP2), also known
as synapse-associated protein 90/postsynaptic density-95-
associated proteins (SAPAP2), is a postsynaptic adapter protein
in mammalian brains (Kindler et al., 2004). DLGAP2 directly
interacts with DLG4 (also known as PSD-95) and Shank
proteins to form the Dlg4-Dlgap-Shanks complex important for
maintaining the PSD structure (Kim et al., 1997; Takeuchi et al.,
1997; Boeckers et al., 1999). The Dlgap2−/− mice have reduced
spine density in the orbitofrontal cortex accompanied with
downregulation of synaptic proteins, Homer1 and αCaMKII,
as well as receptors, NR1 and GluR1, and exhibit exacerbated
aggressive behaviors (Jiang-Xie et al., 2014). Molecular and
genetic studies have demonstrated that alterations in DLGAP2
are involved the pathophysiology of various psychiatric
conditions, including schizophrenia, Alzheimer’s disease,
post-tramautic syndrome, and pediatric obsessive-compulsive
disorder (Chertkow-Deutsher et al., 2010; Wu et al., 2013;
Li et al., 2014b; Chaudhry et al., 2015). Rare de novo CNVs,
deletions, and duplications of DLGAP2 have been reported in
individuals with ASD, but how mutations of DLGAP2 contribute
to autism is still largely unknown (Marshall et al., 2008; Ozgen
et al., 2009; Chien et al., 2010; Pinto et al., 2010; Cukier et al.,
2014).
Molecules Regulating Synaptic Vesicles
Are Implicated in the Regulation of
Neurite Outgrowth
Neurotransmitter release is regulated by the cycling of synaptic
vesicles at the axonal terminal. The regulation of synaptic
vesicles contains several steps and requires precise interaction
of several specialized proteins, including SNARE complex for
membrane fusion and syntaxin for vesicle docking. STXBP5
encodes a syntaxin-binding protein, tomosyn that negatively
regulates neurotransmitter release by forming a syntaxin-
SNAP25-tomosyn complex (Fujita et al., 1998; Sakisaka et al.,
2004; Yizhar et al., 2004; Yamamoto et al., 2009, 2010; Bielopolski
et al., 2014). Neuron-specific tomosyn deletion in mouse
hippocampal dentate gyrus impairs spatial learning and memory,
whereas tomosyn knockdown in dentate gyrus decreases synaptic
plasticity of mossy fibers (Barak et al., 2013; Ben-Simon et al.,
2015). Tomosyn also regulates SNARE complexes via ROCK
phosphorylation of syntaxin-1 to control neurite outgrowth
(Sakisaka et al., 2004). Recent genetic studies have identified the
association of STXBP5 and ASD (Davis et al., 2009; Cukier et al.,
2014; De Rubeis et al., 2014).
PRICKLE1 encodes PRICKLE1 protein, which has been
traditionally thought to regulate the Wnt/beta-catenin signaling
pathway to control epithelial planar cell polarity and cell
migration during neural tube formation (Heitzler et al., 1993;
Carreira-Barbosa et al., 2003; Veeman et al., 2003; Jenny et al.,
2005). Intriguingly, the Prickle1+/− mice exhibit autism-like
behaviors, which may result from disrupted interaction with
synapsin, a regulator of neurotransmitter release, suggesting that
PRICKLE1 plays a critical role in synaptic vesicle regulation
(Paemka et al., 2013). In addition, knockdown of PRICKLE1
in mice results in reduced axonal and dendrite formation in
hippocampal neurons (Liu et al., 2013a). More recently, variants
of PRICKLE1 have been found in individuals with autism (Cukier
et al., 2014; Toma et al., 2014).
Synaptic scaffolds are crucial not only to maintain the
structural stability of dendritic spines and synapses but also
to link the signaling molecules and receptors to efficiently
act in response to certain extracellular stimuli. Mutations in
these molecules may disrupt several different signaling pathways
and result in wide range of cellular defects, which sometimes
are not limited to ASD. In addition, couple autism-associated
genes that have been shown to regulate synaptic vesicles also
play roles in neurite outgrowth or synaptic plasticity thereby
regulating the structural stability of neurons. An interesting
direction of investigation is whether the regulation of synaptic
vesicles represents one of the key vulnerable cellular pathway that
contributes to the alteration of neuronal structures in ASD.
SPECIFIC SYNDROMIC DISORDER
RELATED GENES
Several autism-related neurodevelopmental disorders, such as
Fragile X, Rett, Angelman syndromes (AS), and tuberous
sclerosis are caused by a highly penetrable mutation of a single
gene, e.g., FMR1 in Fragile X (Verkerk et al., 1991; Gedeon et al.,
1992), MECP2 in Rett (Amir et al., 1999), UBE3A in AS (Kishino
et al., 1997), and TSC1/2 in tuberous sclerosis complex (TSC;
Povey et al., 1994). In recent DMS-5 criteria, however, ASD
condition has been separated out from these single gene related
disorders. Interestingly, these molecules all have a major function
in regulating gene expression or protein synthesis, which in
turn widely affects the structural stability of neurons. Because
of the comorbidity between ASD and these single gene related
disorders, we also review the current understanding of these
genes and discuss how alterations of these genes may impair the
structural integrity of neurons.
FMRP
FMRP is a RNA-binding protein encoded by FMR1 gene (Ashley
et al., 1993; Siomi et al., 1993). Mutations of the FMR1 gene in
humans result in CGG repeat polymorphisms or in the deletion
of FMRP protein contributing to Fragile X syndrome, the most
common inherited form of intellectual disability (Verkerk et al.,
1991; Gedeon et al., 1992). Interestingly, people with Fragile X
syndrome often exhibit autistic behaviors and mutations of FMR1
genes are also found in several cases of ASD (Vincent et al., 1996;
Feinstein and Reiss, 1998; Rogers et al., 2001; Hatton et al., 2006;
Chaste et al., 2012; Yu et al., 2013). The absence of FMRP is
associated with widespread morphological changes of dendrites
and dendritic spines in different brain regions, including cortex
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(Comery et al., 1997; Weiler and Greenough, 1999; Irwin et al.,
2000; Greenough et al., 2001; Nimchinsky et al., 2001; Galvez
et al., 2003; Galvez and Greenough, 2005; McKinney et al., 2005;
Bureau et al., 2008; Cruz-Martin et al., 2010; Pan et al., 2010; Qin
et al., 2011; Berman et al., 2012; Amiri et al., 2014; Wijetunge et al.,
2014), hippocampus (Braun and Segal, 2000; Segal et al., 2003;
Antar et al., 2006; Grossman et al., 2010; Levenga et al., 2011a;
Amiri et al., 2014), and cerebellum (Koekkoek et al., 2005).
Upon mGluR-activation, the local translation of Fmr1 in
dendrite and dendritic spines is crucial for maintaining dendritic
structure (Antar et al., 2004; Bear et al., 2004; Tucker et al.,
2006; Osterweil et al., 2010; Pop et al., 2014). The hyperactivation
of mGluR5 signaling, as well as the neuronal and behavioral
deficits resulting from FMRP deficiency can be corrected by
application of a mGluR5 antagonists (Bear et al., 2004; Bear,
2005; Tucker et al., 2006; Dolen et al., 2007; Price et al., 2007;
Wilson and Cox, 2007; Auerbach and Bear, 2010; Osterweil et al.,
2010; Levenga et al., 2011b; Michalon et al., 2012, 2014; Ronesi
et al., 2012; Lohith et al., 2013; Pop et al., 2014). The activation
of FMRP subsequently regulates the local synthesis of several
other synaptic proteins, including AMPAR, CaMKII, and PSD95,
which in turn modulates the activity-dependent dynamics and
plasticity of dendritic spines (Muddashetty et al., 2007; Nakamoto
et al., 2007; Kao et al., 2010; Ifrim et al., 2015). In addition,
the Rac-PAK pathway is upregulated and coincides with the
disruptive dendritic phenotype in the absence of FMRP (Lee
et al., 2003; Hayashi et al., 2007; Chen et al., 2010a; Bongmba
et al., 2011). A rare deletion and several variants of cytoplasmic
FMR1 interacting protein 1 (CYFIP1) are also found in cases of
ASD further suggesting genes involved in the FMRP signaling
pathway are prevalent risk factors (van der Zwaag et al., 2010;
Leblond et al., 2012; Toma et al., 2014; Waltes et al., 2014; Wang
et al., 2015). Interestingly, CYFIP1 mediates FMRP-dependent
protein translation to regulate the dendritic complexity and
the stability of dendritic spines (Napoli et al., 2008; De Rubeis
et al., 2013; Pathania et al., 2014). Overexpression of CYFIP1
results in an increase of dendritic branching and dendritic spine
density (Oguro-Ando et al., 2015). Thus, the understanding of the
molecular mechanisms regulated by FMRP provides insights into
how mutations of FMR1 in ASD may affect neuronal function
and contribute to autistic behaviors.
MECP2
Methyl-CpG binding protein 2 (MECP2) is a transcriptional
factor that has multiple functions in gene regulation (Meehan
et al., 1989; Nan et al., 1997, 1998; Young et al., 2005; Chahrour
et al., 2008; Cheng et al., 2014). Mutations of MECP2 gene
contribute to 90% of cases with Rett syndrome, which is a severe
developmental disorder exhibiting autistic phenotypes (Amir
et al., 1999; Shahbazian and Zoghbi, 2001; Van den Veyver and
Zoghbi, 2001). Interestingly, the MECP2 duplication syndrome
also exhibit phenotypes that resemble those with ASD (Ramocki
et al., 2009; Peters et al., 2013; Lombardi et al., 2015). Mutations
and CNVs of MECP2, including duplication of the gene, have
been identified in people with ASD without the diagnoses of
either Rett or MECP2 duplication syndromes (Carney et al., 2003;
Zappella et al., 2003; Shibayama et al., 2004; Swanberg et al.,
2009; Campos et al., 2011; Schaaf et al., 2011; Cukier et al., 2012;
Hanchard et al., 2012; Lim et al., 2013; Yu et al., 2013). Most
studies on MECP2 function focus on the understanding of the
etiology of Rett syndrome and the MECP2 duplication syndrome.
Upregulation or downregulation of MECP2 dramatically alters
the dendritic and axonal architecture of neurons and significantly
disrupts the connectivity of neuronal networks (Fukuda et al.,
2005; Jugloff et al., 2005; Ballas et al., 2009; Belichenko et al., 2009;
Chapleau et al., 2009; Kishi and Macklis, 2010; Cohen et al., 2011;
Marshak et al., 2012; Nguyen et al., 2012; Stuss et al., 2012; Jiang
et al., 2013a; Baj et al., 2014). Overexpression of BDNF appears to
restore the dendritic defects in Mecp2-null condition suggesting
a molecular mechanism regulated by MECP2 to maintain the
structural stability of neurons (Zhou et al., 2006; Larimore et al.,
2009; Gao et al., 2015). Synaptic plasticity is also regulated by the
expression or the phosphorylation of MECP2 (Collins et al., 2004;
Dani et al., 2005; Asaka et al., 2006; Moretti et al., 2006; Chao
et al., 2007; Zhang et al., 2008; Li et al., 2011; Noutel et al., 2011;
Blackman et al., 2012; Na et al., 2012, 2013; Qiu et al., 2012; Zhong
et al., 2012; Della Sala and Pizzorusso, 2014; Deng et al., 2014;
De Filippis et al., 2015). Whether a similar mechanism to Rett or
MECP2 duplication syndromes is altered in ASD individuals with
MECP2 mutations needs to be further evaluated.
UBE3A
UBE3A gene is a paternally imprinted gene located at human
chromosome 15 and encodes a member of the E3 ubiquitin
ligase proteins (Huibregtse et al., 1993; Albrecht et al., 1997).
Because UBE3A is selectively imprinted in mature neurons,
epigenetic regulation of UBE3A has been associated with several
neurodevelopmental disorders (Albrecht et al., 1997; LaSalle
et al., 2015). Mutations resulting in loss-of-function in the
maternally expressed copy of UBE3A causes AS, a severe
developmental disorder characterized by delayed development,
intellectual disability, severe speech impairment, and ataxia
(Kishino et al., 1997). Maternal duplication of UBE3A results
in Dup15q syndrome, a developmental disorder that has many
similarities with AS but also exhibits several autistic traits
(Cook et al., 1997; Wang et al., 2008; Hogart et al., 2010;
Smith et al., 2011; Urraca et al., 2013; Al Ageeli et al., 2014;
Germain et al., 2014). Coincidently, several genome-wide studies
from individuals with autism identify UBE3A as an autism-risk
gene (Nurmi et al., 2001; Glessner et al., 2009; Schaaf et al.,
2011; Kelleher et al., 2012; Carvill et al., 2013; Iossifov et al.,
2014; Yuen et al., 2015). In addition to its function of ubiquitin
ligase to catalyze the protein degradation step, UBE3A also can
act as a transcriptional coactivator for the nuclear hormone
receptor superfamily of transcription factors (Nawaz et al., 1999).
UBE3A localizes both in the nucleus and cytosol, including
dendrite and pre- and post-synaptic compartments in neurons
to regulate dendrite and dendritic spine morphology (Dindot
et al., 2008; Valluy et al., 2015). Although maternal deletion of
Ube3a does not affect dendrite arborization in mouse brains,
knockdown of UBE3A in cultured neurons results in defects
of dendrite polarization in pyramidal neurons (Dindot et al.,
2008; Miao et al., 2013). Maternal-deficiency of Ube3a in mouse
brain, however, shows defects in dendritic spine development
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in the cortex, hippocampus, and cerebellum (Dindot et al.,
2008; Kim et al., 2016). Furthermore, several neuronal substrates
for UBE3A have been identified, including Arc (Greer et al.,
2010), the Rho-GEF Pbl/ECT2 (Reiter et al., 2006), Ephexin5
(Margolis et al., 2010), and TSC2 (Zheng et al., 2008). Their
regulation by UBE3A provides molecular mechanisms to explain
how synaptic integrity is maintained and how alteration of
this interaction contributes in part to neuronal phenotypes
in neurodevelopmental disorders. In addition, a recent study
demonstrates that a PKA phosphorylation-defective mutation on
UBE3A found in an individual with autism resulted in an increase
of dendritic spine density (Yi et al., 2015).
TSC1/TSC2
TSC1 and TSC2 genes encode protein harmartin and tuberin,
respectively, and they bind and function together (European
Chromosome 16 Tuberous Sclerosis Consortium, 1993; van
Slegtenhorst et al., 1997; van Slegtenhorst et al., 1998). Mutations
of TSC1 or TSC2 genes cause an autosomal dominant disorder
TSC, which is characterized by hamartomas in various organs
(Povey et al., 1994; Crino et al., 2006). Some patients with TSC
exhibit several neurological problems including autism (Smalley,
1998; Bolton, 2004). Similarly, mutations of TSC1 or TSC2 are
also found in several ASD cases (Smalley, 1998; Serajee et al.,
2003; Schaaf et al., 2011; Kelleher et al., 2012; O’Roak et al.,
2012b; Koshimizu et al., 2013; Brett et al., 2014; Toma et al., 2014;
Krumm et al., 2015). TSC1/2 act upstream as to suppress the
mammalian target of rapamycin (mTOR) pathway and mTOR
inhibitors have been promising therapeutic agents to ameliorate
some symptoms in TSC (Gao et al., 2002; Meikle et al., 2008;
Curatolo et al., 2016). One of the mTOR inhibitors, rapamycin,
has also been shown to correct the autistic-like synaptic pruning
deficits in Tsc2+/− mice (Tang et al., 2014). In addition to the
mTOR pathway being the key downstream target for TSC1/2,
LIMK-cofilin pathway is altered upon deletion of TSC1 or TSC2
and enlargement of somas and dendritic spines are observed
(Tavazoie et al., 2005). The Tsc2 mutations result in a loss of
Purkinje cells and Tsc1 mutant mice have increased dendritic
spine density, which correlates with cerebellar dysfunction and
several autistic-like behaviors in animals (Tsai et al., 2012b; Reith
et al., 2013). TSC1/2 also negatively regulates neurite and axonal
outgrowth (Floricel et al., 2007; Choi et al., 2008). It has yet to
be determined whether TSC1/2 mutations in ASD correlate with
perturbations of neuronal structures.
PERSPECTIVES
Diagnosis of ASD cases has risen dramatically in recent years.
The increased awareness of the symptoms and the broader
definition of the spectrum may be major contributing factors
for the rising number of ASD cases. Thus, there is an increased
interest on understanding the etiologies of ASD. It is widely
accepted that the genetic component plays a major role in ASD,
however, except for the direct inheritance of some syndromic
conditions, it is difficult to identify risk factors for autism. It is
possible due to the low sample size and the high heterogeneity
of genetic variances to have sufficient statistical power to make
conclusive correlations (Geschwind and State, 2015). Among
those autism-risk genes identified to date, some of the autism
associations are due to de novo mutations, and some are familial
variants (Table 4). Whether the inheritance pattern exhibits a
risk factor is still not clear, however, the diverse gene mutations
found in different individuals with autism suggest that instead
of focusing on the genes per se, identifying the vulnerable
pathways that these genes regulate may provide better clues
toward understanding the contributing cellular and molecular
changes that reserve in the autism phenotypes. The cellular
defects resulting from different combinations of gene mutations
contribute to the diverse phenotypes observed in autism.
The heterogeneity of symptoms in ASD further complicates
the diagnosis and treatment. However, understanding how
autism-associated genes function in the regulation of key
cellular pathways will provide insights to how therapeutic
intervention can be more targeted and efficient to treat affected
individuals.
Neuroanatomical studies of individuals with autism suggest
a common disruption of neuronal structures with a decrease of
dendrite arborization but an increase of dendritic spine density in
select brain regions (Raymond et al., 1996; Bauman and Kemper,
2005; Hutsler and Zhang, 2010; Tang et al., 2014). This feature
is distinct from other neurodevelopmental disorders, such as
Rett or Fragile X syndromes, where the dendrite arbors and
dendritic spine density are both downregulated (Kulkarni and
Firestein, 2012). Intriguingly, dendrite arborization completes
prior to dendritic spine formation during development. Although
it has been proposed that the pruning mechanism of dendritic
spines is defective in ASD (Frith, 2003), it is also plausible that
the increase of dendritic spine density may be a compensation
to re-establish the sufficient quantity of connections with fewer
dendrite arbors. However, the precise spatial arborization of
dendrites is critical for correct pre- and post-synaptic innervation
when establishing the brain circuitry. The local increase of
dendritic spine density may not be sufficient to compensate the
effect from the loss of dendrite arbors, and may instead result in
abnormal synaptic activity to disrupt normal neuronal function.
This further emphasizes the importance of the establishment
of structural integrity for neurons in order to provide proper
brain function. In addition, the mechanisms of action of many
current pharmacological agents for treating ASD affect normal
neuronal function including the structural stability of neurons.
With the early onset of ASD, the treatment often occurs at
a very young age when the brain is still undergoing the
period of development and maturation. As these pharmacological
treatments may be beneficial to ameliorate some symptoms
in ASD, the general brain development of these individuals
may also be affected (Penagarikano, 2015). Thus, more precise
circuitry-specific therapeutic intervention is needed to reduce
the unwanted effect to the developing brain. Understanding the
genetic and cellular pathways affected in ASD should provide
more selective candidates for developing targeted intervention.
Although the list of autism-associated genes that regulate
neuronal structures is extensive, it stands out that several
genes actually function in the same signaling pathways
Frontiers in Cellular Neuroscience | www.frontiersin.org 15 November 2016 | Volume 10 | Article 263
fncel-10-00263 November 15, 2016 Time: 15:51 # 16
Lin et al. Autism Genes Regulate Neuronal Structures
(Table 5). For example, the mGluR5 pathway is disrupted when
Shank3 (Verpelli et al., 2011), Fmr1 (Giuffrida et al., 2005; Dolen
et al., 2007; Price et al., 2007; Wilson and Cox, 2007; Hays
et al., 2011; Ronesi et al., 2012), Ube3a (Pignatelli et al., 2014),
or Mecp2 (Zhong et al., 2012) gene is altered. Application of
mGluR5 antagonists has been shown to be promising to restore
some phenotypes experimentally in neurons or animals with
Fmr1 mutants (Price et al., 2007; Wilson and Cox, 2007; Levenga
et al., 2011b; Michalon et al., 2012, 2014; Ronesi et al., 2012;
Pop et al., 2014). Whether targeting mGluR5 pathway can be
clinically effective for ASD with mutations beyond FMR1 will
require further investigation. The mTOR pathway is defective
when Pten (Jaworski et al., 2005; Kwon et al., 2006; Zhou et al.,
2009; Pun et al., 2012), Tsc1/2 (Gao et al., 2002; Meikle et al.,
2008; Curatolo et al., 2016), or Mecp2 (Ricciardi et al., 2011)
gene is mutated. However, the mTOR pathway is upregulated in
mice carrying defective gene products of Pten, Tsc1/2, or Fmr1,
but downregulated in Mecp2-null mice. The mTOR inhibitor,
rapamycin, has been shown to be effective to rescue some
phenotypes caused by these mutations and has been used as
a therapeutic agent to treat some of the autism symptoms
(Meikle et al., 2008; Ehninger and Silva, 2011; Curatolo et al.,
2016). The alteration of IGF-1/GSK3β pathway is implicated
in Pten (Kwon et al., 2006), Cdk5l (Fuchs et al., 2014) or
Mecp2 (Itoh et al., 2007) mutant animals. Inhibition of GSK3β
or application of IGF-1 can rescue the dendritic phenotype
in Cdk5l and Mecp2 mutant mice (Tropea et al., 2009; Fuchs
et al., 2015; Della Sala et al., 2016). The mTOR pathway and
the GSK3β pathway can be further linked together as they are
both regulated by AKT. In addition, Rac1 activity is altered
when Elmo1 (Grimsley et al., 2004), Cdk5l (Chen et al., 2010b),
Shank3 (Duffney et al., 2015), or Fmr1 (Lee et al., 2003; Chen
et al., 2010a; Bongmba et al., 2011) is mutated suggesting its
crucial role to maintain the stability of neurons. The potential
therapeutic approach targeting the Rac1 pathway to rescue
the neuronal and behavioral phenotype in mutant animals is
actively under investigation (Hayashi et al., 2007; Duffney et al.,
2015).
To date, several animal studies have tried to model the
behavior phenotypes in autism, however, there remains a
debate as to whether rodents can sufficiently recapitulate the
complexities of the condition in human. The heterogeneity of
genetic components also make it difficult to establish reliable
animal models to describe the cellular and molecular mechanistic
alterations in specific pathways. However, the studies on rodents
can suggest which brain circuitry should be the area of interest for
the corresponding behavior. iPSCs derived from ASD individuals
appear to be an attractive model systems that allow researchers
to directly investigate the interaction between the genetic
contribution and the autism-relevant phenotypes. However, what
is lacking in this system is a physiological relevant environment
to correlate the behavior and the cellular phenotype. A recent
emerging genetic editing technique, CRISPR/Cas9 (Jinek et al.,
2012), is a powerful tool to study the mechanistic questions
and identify the potential therapeutic interventions. Unlike the
traditional knock-in or knock-out technique, CRISPR/Cas9 can
introduce genomic editing of several genes at once. Using
CRISPR/Cas9 in iPSCs can potentially determine the genetic
contribution to the cellular phenotypes and provide a mechanism
to correct them. However, there is still room for improvement of
the efficiency and precision before this technique can be reliably
used in clinical applications. Combining animal studies, iPSC
models, and gene editing techniques, it is now possible to perform
more comprehensive translational research in order to better
understand the etiologies of ASD and design more efficient and
effective therapeutic interventions.
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